Numedico™ Technologies: Revolutionising Healthcare in the Modern Era

Top 10 MedTech Startups in APAC - 2020

The unprecedented crisis that the recent COVID-19 pandemic has brought forth is now pushing the existing healthcare systems to scale at pace. And to this end, digital transformation is playing a crucial role by helping the healthcare systems adapt to this new world. The use of innovative MedTech devices and AI application in providing care to patients are continually becoming more commonplace.

This is also accompanied by other critical changes, particularly around the deployment of a whole gamut of new medical devices and products, including wearables. These devices have many potential entry points in the best management of COVID-19 pandemics: from monitoring mild cases at home to offering personalized care to patients post-discharge from hospitals. And today, with the proliferation of 5G infrastructure and the very sudden increase in take-up, these MedTech devices are further leading to a veritable explosion in the number of data points that are going to become available to different healthcare systems globally.

By and large, it is implausible that this is a temporary phase. Therefore, MedTech companies should consider other imperatives beyond the immediate crisis response— particularly over the next three to nine months—to strengthen crisis resilience and recovery plans. For example, there is a real urgency to gather insights and deploy AI for identifying areas of future risk and opportunity, while improving and personalizing the care of people.

At this juncture, many MedTech Startups are entering the industry with a set of advanced and integrated offerings. Our editorial team has compiled a list of the top 10 MedTech Startups to help care providers improve their services and simultaneously ensure enhanced patient safety. Besides, the magazine also includes insights from thought leaders in the sector on the industry trends, best practices, latest innovations, and their advice for the aspiring CIOs.

We present to you MedTech Outlook’s “Top 10 MedTech Startups in APAC - 2020.”

Top MedTech Startups in APAC

Numedico^™ Technologies

An Australian-based medical devices firm, Numedico^™ Technologies offers a first-of-its-kind high-quality retractable safety syringe, ClickZip^™, which provides valuable protection for healthcare workers, their patients, and others in the community by preventing the spread of disease, infection, and blood-borne pathogens. Today, Numedico is recognised as a leading Australian-based manufacturer of safety medical devices and the manufacturer/distributor of ClickZip^™ Needle Retractable Safety Syringe technology. ClickZip^™ is only one of Numedico Technologies products, and the firm’s offerings go beyond ClickZip^™ to include retractable safety butterfly needles for blood collection, virus collection and preservation sets, high-quality surgical-grade face masks, and a regulated medical waste management system

OncoRes Medical

OncoRes Medical is developing an intraoperative imaging tool that translates the surgeon's sense of touch into a mircoscale image — improving surgical accuracy and reducing complication rates. Founded in 2016, OncoRes is a medical device company funded by the Medical Research Commercialisation Fund, developing patent-protected technology in collaboration with leading researchers at the University of Western Australia, the Harry Perkins Institute of Medical Research and breast cancer surgeons from the Western Australian Department of Health

Apollo Medical Optics

Apollo Medical Optics (AMO) develops optical coherence tomography imaging devices. With the unique light source originated from National Taiwan University, the in vivo cellular imaging system provides clinicians a non-invasive tool to capture three-dimensional cellular resolution images. AMO's system targets to allow clinicians to reduce the numbers and frequency of skin biopsies. The company aims to focus on the clinical development of its device for dermatology, followed by the establishment of an OCT database for dermatology and pathology. By licensing to foreign agents, AMO will cooperate with international associations of dermatology and pathology to promote the use of its OCT medical devices

BionicM

BionicM is pursuing for powering mobility for all including handicapped and non-handicapped by fusing robotics technology and human body. BionicM has been conducting research on innovative technologies since 2015 at the University of Tokyo's Information Systems Engineering Laboratory (JSK) under the guidance of Professor Inaba and utilizing the world's most advanced robotics research. As a venture from the University of Tokyo, BionicM will utilize cutting-edge technology based on robotics engineering research to solve the problems of conventional artificial limbs and create compact and lightweight high-performance artificial limbs that realize natural movement

Credo Diagnostics Biomedical

Credo Diagnostics Biomedical develops, manufactures, and commercializes innovative, cost-effective, and rapid Molecular Diagnostic solutions at the Point-of-Care (POC) in the areas of human infectious diseases, animal health and human wellness. At Credo Diagnostics Biomedical, we are conscious of the necessity to simplify processes and accelerate molecular testing at lower costs. We believe that effective rapid POC Molecular Diagnostics will redefine healthcare for both human and veterinary clinical management. By providing the right information, at the right time, and to the right people, we can improve the lives of billions of people and animals around the world

Fourier Intelligence

Fourier Intelligence is a technology-driven company, infusing creativity into the development of exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists and patients, Fourier aim to excel in developing and redefining rehabilitation robotics solutions with interconnectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists. Together, Fourier is passionately driven to create intelligent rehabilitation solutions that are beneficial to the recovery of patients, as well as the efficiency of clinicians

Fusetec

Fusetec is a cutting-edge Additive Manufacturing company utilising latest 3D technologies. Working alongside notable medical professionals to provide exacting anatomical models to enhance medical training. In addition, Fusetec specialise in multi-material replications of specific pathologies for pre-operative medical evaluation, education and training. The company is currently developing its own Intellectual Property for healthcare training products

Medi Whale

Medi Whale suggests the fastest way to detect human diseases beyond human cognition. The company was founded to develop an artificial intelligence that enables to look through the whole body health using an eye as a window. The company devoted to providing a simple but effective solution for disease detection in primary care. At core, Medi Whale believe that there must be a new intelligence :an intelligence for better human health

MEIK

Health care delivery management, efficiency, and cost reduction is an on-going debate and a subject studied and continue to be studied by commissions, task forces, panels, and forums set up by governments and private interest groups. In order to constructively participate in this debate, we at MEIK Asia focus on two main areas of health care delivery which are guided by the following principles. MEIK supplies hi-tech medical devices, provide technical support, application trainings and consultation

Pioneer Medical

Pioneer Medical Group is a private medical device group, which supplies and supports; innovative, safe and efficient solutions to Orthopaedic and Neuro Surgeons, operating room teams, and patients across New Zealand. Everything the company does is about its customers, so all the values are aligned with this philosophy and absolute focus. In essence PMG was started this company to serve its customers, so they could treat patients better. Four years down the track and this philosophy is working well